Redesign of glycopeptide antibiotics: back to the future.

ACS Chemical Biology
Robert C JamesDale L Boger

Abstract

The glycopeptide antibiotics are the most important class of drugs used in the treatment of resistant bacterial infections including those caused by methicillin-resistant Staphylococcus aureus (MRSA). After more than 50 years of clinical use, the emergence of glycopeptide-resistant Gram-positive pathogens such as vancomycin-resistant enterococci (VRE) and vancomycin-resistant Staphylococcus aureus (VRSA) presents a serious global challenge to public health at a time few new antibiotics are being developed. This has led to renewed interest in the search for additional effective treatments including the development of new derivatives of the glycopeptide antibiotics. General approaches have been explored for modifying glycopeptide antibiotics, typically through the derivatization of the natural products themselves or more recently through chemical total synthesis. In this Perspective, we consider recent efforts to redesign glycopeptide antibiotics for the treatment of resistant microbial infections, including VRE and VRSA, and examine their future potential for providing an even more powerful class of antibiotics that are even less prone to bacterial resistance.

References

Jan 1, 1982·Pharmacology & Therapeutics·H R Perkins
Sep 16, 1998·Antimicrobial Agents and Chemotherapy·C G MarshallG D Wright
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·M Arthur, R Quintiliani
Jul 18, 2001·Journal of the American Chemical Society·D L BogerJ J McAtee
Jul 27, 2002·Annual Review of Microbiology·Timothy R Walsh, Robin A Howe
Feb 15, 2003·FEMS Microbiology Reviews·Norris E Allen, Thalia I Nicas
Apr 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lan ChenDaniel Kahne
Aug 2, 2003·Journal of the American Chemical Society·Casey C McComasDale L Boger
Dec 1, 1964·Postgraduate Medical Journal·M T PARKER, M P JEVONS
Apr 1, 2004·Journal of the American Chemical Society·Brendan M CrowleyDale L Boger
Feb 11, 2005·Chemical Reviews·Dan KahneChristopher Walsh
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrice Courvalin
Sep 17, 2008·Advances in Experimental Medicine and Biology·Hee-Jeon HongUNKNOWN Biotechnology and Biological Sciences Research Council, UK
Jun 27, 2009·Scientific American·Christopher T Walsh, Michael A Fischbach
Oct 21, 2009·Journal of the American Chemical Society·Joie GarfunkleDale L Boger
Dec 2, 2009·Nature Reviews. Drug Discovery·G Ralph CoreyPeter Kirkpatrick
Apr 13, 2010·Nature Chemical Biology·Kalinka KotevaGerard D Wright
May 18, 2010·Journal of the American Chemical Society·Hiroyuki ShimamuraDale L Boger
Jun 24, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K HegstadA Sundsfjord
Sep 3, 2010·Nature Reviews. Drug Discovery·Bashar Hamad
Feb 3, 2011·Chemical Communications : Chem Comm·Gerard D Wright
Oct 14, 2011·Journal of the American Chemical Society·Steven P Breazzano, Dale L Boger
May 3, 1999·Angewandte Chemie·Dudley H Williams, Ben Bardsley

❮ Previous
Next ❯

Citations

Jan 10, 2013·Journal of the American Chemical Society·Steven P BreazzanoDale L Boger
Jun 13, 2013·The Journal of Antibiotics·Christopher T Walsh, Timothy A Wencewicz
Sep 15, 2016·ACS Infectious Diseases·Venkateswarlu YarlagaddaJayanta Haldar
Jan 5, 2016·Bioorganic & Medicinal Chemistry Letters·Tyler J WadzinskiScott J Miller
Oct 21, 2014·Journal of the American Chemical Society·Rodrigo A RodriguezPhil S Baran
Sep 17, 2013·Angewandte Chemie·Kieron M G O'ConnellDavid R Spring
Jul 22, 2014·Chemistry : a European Journal·Jiyong Hong
Jul 6, 2014·Angewandte Chemie·Peter M WrightAndrew G Myers
May 9, 2014·Chemistry : a European Journal·Juan TreviñoMaría J Hernáiz
Jun 24, 2015·Bioorganic & Medicinal Chemistry Letters·Nataliia V ShymanskaJoshua G Pierce
Mar 24, 2016·Angewandte Chemie·Mathieu F ChellatRainer Riedl
Oct 30, 2014·The Journal of Antibiotics·Venkateswarlu YarlagaddaJayanta Haldar
Jul 25, 2013·Bioorganic & Medicinal Chemistry Letters·Joseph R Pinchman, Dale L Boger
Mar 12, 2015·Nature Communications·Ming YangAng Li
Oct 11, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P Sendi, W Zimmerli
Apr 27, 2016·Current Opinion in Biotechnology·Andrew C PawlowskiGerard D Wright
Jun 11, 2016·ACS Chemical Biology·Oleksandr YushchukLiliya Horbal
Apr 23, 2015·International Journal of Antimicrobial Agents·Venkateswarlu YarlagaddaJayanta Haldar
May 23, 2013·Journal of the American Chemical Society·Tejas P Pathak, Scott J Miller
Mar 13, 2014·The Journal of Organic Chemistry·Christie L Beck, Arthur H Winter
Nov 4, 2015·Bioorganic & Medicinal Chemistry Letters·Venkateswarlu YarlagaddaJayanta Haldar
Oct 11, 2016·Biochemical Pharmacology·Rustam Aminov
Apr 25, 2017·Chemical Reviews·Akinori OkanoDale L Boger
Jun 1, 2017·Proceedings of the National Academy of Sciences of the United States of America·Akinori OkanoDale L Boger
Dec 18, 2013·Antimicrobial Agents and Chemotherapy·Dereje Dadi GudetaLuca Guardabassi
Apr 27, 2019·Antibiotics·Bernardo Ribeiro da CunhaCecília R C Calado
Oct 11, 2019·Medicinal Research Reviews·Xiaoshu Jing, Kang Jin
Feb 23, 2020·Applied Microbiology and Biotechnology·Oleksandr YushchukVictor Fedorenko
Jan 1, 2014·Antibiotics·Elisa BindaGiorgia Letizia Marcone
Nov 18, 2017·Soft Matter·Mintai P HwangYadong Wang
Jan 19, 2021·ACS Omega·Olatunde P OlademehinKevin L Shuford
Oct 20, 2020·Organic Letters·Christopher GartshoreDale L Boger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.